SCHEMBL5650102

SCHEMBL5650102

COc1cc2c(NC3=CC(=O)C(OCc4cccnc4)=CC3=O)ncnc2cc1OCCCN1CCCC1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.85
EGFR P00533 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651353 0.92 KDR (1.00) KDREGFR
SCHEMBL5647364 0.88 KDR (0.85) KDREGFR
SCHEMBL5651836 0.88 KDR (1.00) KDREGFR
SCHEMBL5650552 0.87 KDR (1.00) KDREGFR
SCHEMBL5650380 0.87 KDR (0.86) KDREGFR
SCHEMBL5651796 0.86 KDR (0.81) KDREGFR
SCHEMBL5647584 0.86 KDR (1.00) KDR
SCHEMBL5651217 0.85 KDR (0.82) KDREGFR
SCHEMBL5650536 0.85 KDR (0.82) KDREGFR
SCHEMBL5654134 0.85 KDR (0.95) KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 KDR 1/4885EGFR 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.